Isocitrate Dehydrogenase 2 Inhibitor
- Name
- Isocitrate Dehydrogenase 2 Inhibitor
- Accession Number
- DBCAT003837
- Description
Not Available
- Drugs
Drug Drug Description Enasidenib An isocitrate dehydrogenase-2 inhibitor used to treat relapsed or refractory acute myeloid leukemia with an isocitrate dehydrogenase-2 mutation. - Drugs & Drug Targets